Abstract:The development of highly efficient and minimally toxic agents with targeting abilities toward tumor tissues is an ongoing area of research in the fight against cancer. Different from the mononuclear and multinuclear metallodrug complexes, impressively, the unique supramolecular coordination complexes (SCCs) have shown great superiority in cancer treatment. The vast combinational flexibility of ligands and metal ions offers limitless opportunities to form desired SCCs, thus endows them with distinct, captivating and integrated biological and chemical properties. Compared to organic drugs that are predominantly one-dimensional (1D) or two-dimensional (2D) in shape, the structurally much more complicated three-dimensional (3D) multinuclear assemblies with elaborate sizes, shapes, or cavities can exhibit unexpected binding sensitivity and selectivity toward biomolecules. Over the last decades, significant progress has been made in the design and synthesis of novel SCCs for intensive cancer therapy. These assemblies have been formulated using new strategies and formulations, resulting in nonclassical action modes that show promising results. This review aims at gathering innovative multinuclear Pt(II), Ru(II), and Ir(III)-based metallo-assemblies as promising anticancer drugs. Each section is divided into different parts based on the number of metal ions and shapes of the assembly. Furthermore, the review concludes with an exploration of the regulatory factors of structure design and discusses the perspectives for the practical impact of this type of research in medicinal chemistry. It is expected that this review will afford important guidance for the further development of these promising anticancer agents in biological applications, resulting in innovative anticancer agents that continue along this already promising path.

Pt(II) and Au(III) complexes containing Schiff-base ligands: A promising source for antitumor treatment

Towards the Rational Design of Platinum(ii) and Gold(iii) Complexes As Antitumour Agents

Metal-based Anticancer Chemotherapeutic Agents.

Recent Advances in Ruthenium and Platinum Based Supramolecular Coordination Complexes for Antitumor Therapy

Metal-N-heterocyclic carbene complexes as anti-tumor agents

Pt(IV) Complexes in the Search for Novel Platinum Prodrugs with Promising Activity

Research progress of natural product-conjugated platinum and gold complexes as potential antitumor agents

Antitumor Activity of Pt(II), Ru(III) and Cu(II) Complexes

Biomedical applications of multinuclear Pt(II)/Ru(II)/Ir(III) metallo-supramolecular assemblies for intensive cancer therapy

Supramolecular Delivery Systems for Non-Platinum Metal-Based Anticancer Drugs

Recently Reported Biological Activities and Action Targets of Pt(II)- and Cu(II)-Based Complexes

Platinum(IV) antitumor complexes and their nano-drug delivery

The Therapeutic Potential in Cancer of Terpyridine‐Based Metal Complexes Featuring Group 11 Elements

Metal complexes as photochemical nitric oxide precursors : Potential applications in the treatment of tumors

Recent development of Schiff-base metal complexes as therapeutic agents for lung cancer

Monofunctional Platinum(II) Anticancer Agents

Fresh platinum complexes with promising antitumor activity.

A review on metal complexes and its anti-cancer activities: Recent updates from in vivo studies

DNA interactive and selective anticancer activity studies of copper(II) complexes decorated water‐soluble porphyrin

Synthesis and DNA Interactions Study of Novel Fluorinated Pyridinium Platinum (IV) Complexes with Tumor Targeting Activity

Supramolecular Coordination Complexes As Diagnostic and Therapeutic Agents